A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma
Background: Although DBT is strongly associated with human tumorigenesis and progression through a variety of pathways, the role of DBT in clear cell renal cell carcinoma (ccRCC) has not been well established.Materials and methods: The Cancer Genome Atlas (TCGA)-Kidney renal clear cell carcinoma (KI...
Main Authors: | Wenjie Xie, Ping Xi, Yifu Liu, Zhicheng Zhang, Ting Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1002588/full |
Similar Items
-
Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration
by: Chiyu Zhang, et al.
Published: (2023-06-01) -
OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization
by: Zongming Jia, et al.
Published: (2023-09-01) -
Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
by: Ming Sun, et al.
Published: (2022-10-01) -
Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
by: Yulin Deng, et al.
Published: (2022-11-01) -
A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
by: Kun Meng, et al.
Published: (2023-01-01)